跳至主要内容
临床试验/ACTRN12623000110684
ACTRN12623000110684尚未招募未知

The ‘heart rate’ for the lungs: evaluating respiratory-specific parameters to optimise exercise prescription for people with chronic lung disease

Dr Hayley Lewthwaite0 个研究点目标入组 30 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Are aged 18 years or older
  • Self-report being previously diagnosed with COPD by a medical doctor
  • Meet spirometric criteria for COPD according to Global initiative for Obstructive Lung Disease criteria (forced expiratory volume in 1-sec to forced vital capacity ratio of <0.70 and/or less than the lower limit of normal)
  • Are willing and able to participate in a 6-week exercise training intervention involving cycle exercise

排除标准

  • Have contraindications to lung function testing in accordance with international clinical guidelines13 (American Thoracic Society/European Respiratory Society; heart attack; lung collapse; blood clot in the lung; aneurysm; eye, chest or stomach surgery; or any history of coughing up significant amounts of blood in the previous 3 months)
  • Have significant extra-pulmonary disease that could impair exercise tolerance
  • Have an important contraindication(s) to cardiopulmonary exercise testing (e.g., significant cardiovascular, musculoskeletal, neurological disease)
  • Changed their respiratory medication dosage and/or frequency of administration in the preceding two weeks
  • Had a disease exacerbation/hospitalisation in preceding six weeks

研究者

发起方
Dr Hayley Lewthwaite

相似试验